Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications
- PMID: 40306110
- DOI: 10.1016/j.intimp.2025.114708
Natural bioactive compounds reprogram bile acid metabolism in MAFLD: Multi-target mechanisms and therapeutic implications
Abstract
Metabolic-associated fatty liver disease (MAFLD) has become an increasingly prevalent liver disorder worldwide, being closely associated with obesity, metabolic syndrome, and insulin resistance. Bile acids (BAs), beyond their traditional role in lipid digestion, play a pivotal part in regulating lipid and glucose metabolism as well as inflammatory responses. Recent investigations have recognized BAs as key factors in the onset and progression of MAFLD, mainly via their interactions with nuclear receptors such as the farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor (TGR5). Additionally, active compounds derived from traditional Chinese medicine (TCM) have shown promising potential in the treatment of MAFLD. This study systematically reviews and analyzes the molecular mechanisms and recent progress in the application of TCM active ingredients for MAFLD treatment, with a focus on their regulation of BAs. These active ingredients, including saponins, flavonoids, polysaccharides, and sterols, exert therapeutic effects through diverse mechanisms, such as modulating BA synthesis and mediating receptor-signaling pathways, and are expected to restore metabolic homeostasis.
Keywords: Active ingredients of traditional Chinese medicine; Bile acid metabolism; MAFLD; Mechanism of action; Metabolic-associated fatty liver disease; Research progress.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The Active Components of Traditional Chinese Medicines Regulate the Multi-Target Signaling Pathways of Metabolic Dysfunction-Associated Fatty Liver Disease.Drug Des Devel Ther. 2025 Apr 9;19:2693-2715. doi: 10.2147/DDDT.S514498. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40231197 Free PMC article. Review.
-
Bile acid receptors in non-alcoholic fatty liver disease.Biochem Pharmacol. 2013 Dec 1;86(11):1517-24. doi: 10.1016/j.bcp.2013.08.015. Epub 2013 Aug 26. Biochem Pharmacol. 2013. PMID: 23988487 Free PMC article. Review.
-
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.Semin Liver Dis. 2021 Nov;41(4):461-475. doi: 10.1055/s-0041-1731707. Epub 2021 Jul 21. Semin Liver Dis. 2021. PMID: 34289507 Free PMC article. Review.
-
Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.Int J Biol Sci. 2020 Jun 14;16(13):2308-2322. doi: 10.7150/ijbs.44774. eCollection 2020. Int J Biol Sci. 2020. PMID: 32760200 Free PMC article. Review.
-
Bile acid-mediated gut-liver axis crosstalk: the role of nuclear receptor signaling in dynamic regulation of inflammatory networks.Front Immunol. 2025 May 19;16:1595486. doi: 10.3389/fimmu.2025.1595486. eCollection 2025. Front Immunol. 2025. PMID: 40458398 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical